Flat-rate pricing · All-inclusive pricing No commitment required Prescription included · 100% online · Dose adjustment supported · Free consultation Additive-free options · Multiple pharmacy options · Third-party tested Free expedited shipping · Supplies included · Discreet packaging Tirzepatide, Semaglutide · Zepbound, Mounjaro, Ozempic, Wegovy Available in all 50 states with some pharmacy restrictions Auto-renewing plans Video consultation requiredProvider Plans Monthly Plan Tirzepatide Monthly
Pharmacy Hub (503A) Beaker (503A)
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $250.00 10mg $250 $25.00/mg 5.0mg/wk 20mg/mo $250.00 20mg $250 $12.50/mg 7.5mg/wk 30mg/mo $250.00 30mg $250 $8.33/mg 10.0mg/wk 40mg/mo $250.00 40mg $250 $6.25/mg 12.5mg/wk 50mg/mo $250.00 50mg $250 $5.00/mg 15.0mg/wk 60mg/mo $250.00 60mg $250 $4.17/mg
Mounjaro Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo N/A 10mg N/A N/A 5.0mg/wk 20mg/mo N/A 20mg N/A N/A 7.5mg/wk 30mg/mo N/A 30mg N/A N/A 10.0mg/wk 40mg/mo N/A 40mg N/A N/A 12.5mg/wk 50mg/mo N/A 50mg N/A N/A 15.0mg/wk 60mg/mo N/A 60mg N/A N/A
Zepbound Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo N/A 10mg N/A N/A 5.0mg/wk 20mg/mo N/A 20mg N/A N/A 7.5mg/wk 30mg/mo N/A 30mg N/A N/A 10.0mg/wk 40mg/mo N/A 40mg N/A N/A 12.5mg/wk 50mg/mo N/A 50mg N/A N/A 15.0mg/wk 60mg/mo N/A 60mg N/A N/A
Provider Details In-House Rx Dose Adjustments By Provider
Prescription Included Yes
Telehealth Included Yes
Online-Only Option Yes
Skip Labs Not Disclosed
Insurance Accepted No
HSA/FSA Accepted Yes
Financing Available Yes
LegitScript Certified Yes
HIPAA Compliant Yes
Mobile App Not Disclosed
Supplies Included Cold-Packed
Free Shipping Yes
Expedited Shipping Yes
Discreet Packaging Yes
Format: Injection Brands: Ozempic Pen · Wegovy Pen · +2
Offers Tirzepatide Yes
Offers Semaglutide Yes
Offers Brand Yes
Other Treatments Yes
Phone (650) 300-4334
Address 42 West 24th Street, New York NY 10010
Provider Notes Compliance The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
General Heally is a telehealth facilitator: it routes to Eli Lilly Direct for brand Zepbound and to state-licensed compounding pharmacies for compounded GLP-1.